Home/Filings/4/0001728117-23-000055
4//SEC Filing

Christian Waage 4

Accession 0001728117-23-000055

CIK 0001728117other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:18 PM ET

Size

22.1 KB

Accession

0001728117-23-000055

Insider Transaction Report

Form 4
Period: 2023-05-05
Christian Waage
EVP, Tech Ops and Admin
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-05105,0000 total
    Exercise: $22.10Exp: 2029-03-25Common Stock (105,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-05190,0000 total
    Exercise: $11.94Exp: 2032-01-05Common Stock (190,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-05-05+60,00060,000 total
    Exercise: $1.36Exp: 2031-02-25Common Stock (60,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-05-05+126,667126,667 total
    Exercise: $1.36Exp: 2032-01-05Common Stock (126,667 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-0571,5000 total
    Exercise: $14.55Exp: 2030-02-14Common Stock (71,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-0590,0000 total
    Exercise: $9.79Exp: 2031-02-25Common Stock (90,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-05-05+70,00070,000 total
    Exercise: $1.36Exp: 2029-03-25Common Stock (70,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-05-05+47,66747,667 total
    Exercise: $1.36Exp: 2030-02-14Common Stock (47,667 underlying)
Footnotes (9)
  • [F1]The shares subject to the option are fully vested.
  • [F2]On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 70,000 options to purchase common stock having a lower exercise price with the same vesting terms.
  • [F3]25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F4]On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 47,667 options to purchase common stock having a lower exercise price with the same vesting terms.
  • [F5]25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F6]On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 60,000 options to purchase common stock having a lower exercise price with the same vesting terms.
  • [F7]One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F8]On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 126,667 options to purchase common stock having a lower exercise price with the same vesting terms.
  • [F9]The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001553179

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:18 PM ET
Size
22.1 KB